Submitted by Anonymous (not verified) on 28 October 2025 - 15:18
Human medicines European public assessment report (EPAR): Votrient, pazopanib, Date of authorisation: 14/06/2010, Revision: 32, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Votrient, pazopanib, Date of authorisation: 14/06/2010, Revision: 32, Status: Authorised